Page last updated: 2024-08-18

thiophenes and Cirrhoses, Experimental Liver

thiophenes has been researched along with Cirrhoses, Experimental Liver in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aihara, Y; Asada, K; Douhara, A; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Takeda, K; Yoshiji, H1
Ahn, CY; Bae, SH; Bae, SK; Jung, YS; Kim, T; Kim, YC; Lee, MG; Shin, WG1
Bae, SK; Cho, MK; Kang, KW; Kim, CW; Kim, SG; Kim, YG; Lee, MG1
Bae, SK; Kim, SG; Lee, I; Lee, JY; Lee, MG; Lee, SJ; Lee, Y1
Ercan, F; Gedik, N; Sehirli, AO; Sener, G; Toklu, HZ; Yuksel, M1
Choi, SH; Ha, JR; Kang, KW; Kim, CW; Kim, SG1

Other Studies

6 other study(ies) available for thiophenes and Cirrhoses, Experimental Liver

ArticleYear
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
    Journal of gastroenterology, 2016, Volume: 51, Issue:12

    Topics: Animals; Body Weight; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucosides; Hepatic Stellate Cells; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Cirrhosis, Experimental; Male; Obesity; Organ Size; Rats, Inbred OLETF; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes

2016
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
    British journal of pharmacology, 2009, Volume: 156, Issue:6

    Topics: Animals; Area Under Curve; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Liver; Liver Cirrhosis, Experimental; Pyrazines; Rats; Schistosomicides; Thiones; Thiophenes

2009
Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:14

    Topics: Animals; CCAAT-Enhancer-Binding Proteins; Extracellular Matrix; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Models, Biological; Pyrazines; Rats; RNA, Messenger; Survival Analysis; Thiones; Thiophenes; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    International journal of pharmaceutics, 2004, May-04, Volume: 275, Issue:1-2

    Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Dimethylnitrosamine; Injections, Intravenous; Liver Cirrhosis, Experimental; Male; Microsomes, Liver; Protein Binding; Pyrazines; Rats; Rats, Sprague-Dawley; Schistosomicides; Thiones; Thiophenes; Time Factors; Tissue Distribution

2004
Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
    Pediatric surgery international, 2007, Volume: 23, Issue:3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytokines; Expectorants; Glutathione; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Microbial Collagenase; Oxidative Stress; Peroxidase; Rats; Thioglycolates; Thiophenes

2007
Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression.
    Chemico-biological interactions, 2002, Jan-22, Volume: 139, Issue:1

    Topics: Animals; Base Sequence; Dimethylnitrosamine; DNA Primers; Glyceraldehyde-3-Phosphate Dehydrogenases; Liver Cirrhosis, Experimental; Pyrazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiones; Thiophenes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2002